FDA Approved: ARIPIPRAZOLE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex Corp.'s supplemental application for aripiprazole, enabling the generic version to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autistic Disorder
• Bipolar Disorder
• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

SUPPL AP for ARIPIPRAZOLE (ARIPIPRAZOLE)